≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Carcinoma in situ of skin of upper limb, including shoulder

DOID EFO Endpoint Browser

CD2_INSITU_SKIN_UPPERLIMB

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D04.6&
  • Hospital discharge: ICD-9 — 2326
  • Cause of death: ICD-10 — D04.6&
  • Cause of death: ICD-9 — 2326

2 out of 7 registries used, show all original rules.

720

4. Check minimum number of events

None

720

5. Include endpoints

None

720

6. Filter based on genotype QC (FinnGen only)

720

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D04
Name in latin
Carcinoma in situ cutis regionis deltoideae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 720 327 393
Unadjusted period prevalence (%) 0.15 0.11 0.17
Median age at first event (years) 75.55 76.10 75.09

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
619
Matched controls
6187
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
+∞
323.0
616
*
L57.0
ICD-10 Finland
Actinic keratosis
32.4
295.8
467
535
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
23.5
237.0
390
417
TQW99
NOMESCO Finland
Other minor procedure on skin
21.7
159.8
249
186
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
32.4
140.1
188
82
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
29.3
124.9
172
80
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
34.2
123.6
163
64
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
14.4
121.1
223
233
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
10.1
115.2
265
425
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
84.5
105.9
117
17
R23.8
ICD-10 Finland
Other and unspecified skin changes
7.8
102.3
290
629
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
9.8
92.8
209
305
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
98.1
91.2
99
12
ZXC50
NOMESCO Finland
Cryotherapy
15.5
90.8
157
133
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
16.4
85.3
143
111
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
14.9
84.9
149
129
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
10.1
81.7
177
235
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
23.3
78.6
115
60
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
14.3
76.1
135
118
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
26.3
74.0
104
47
D06BB10
ATC
imiquimod; topical
10.8
67.5
138
160
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
77.3
67.0
75
11
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
27.1
66.9
93
40
S18
ICPC
Laceration/cut
4.4
63.7
433
2148
ZXC15
NOMESCO Finland
Use of photodynamic technique
21.4
63.4
95
52
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
48.0
62.7
76
18
127
Kela drug reimbursment
Transplant complication
41.7
61.8
77
21
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
15.5
57.5
97
73
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
44.7
55.4
68
17
ZQZ00
NOMESCO Finland
Treatment of several skin areas
44.4
52.1
64
16
Z94.0
ICD-10 Finland
Kidney transplant status
36.1
48.3
62
19
ZZR00
NOMESCO Finland
Flap of skin
11.9
46.9
89
86
ZXC20
NOMESCO Finland
Use of chemical agents
11.5
46.1
89
89
XQ848
NOMESCO Finland
Dermatological photography
11.4
42.9
83
83
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
27.7
42.4
58
23
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
30.4
39.7
53
19
L82
ICD-10 Finland
Seborrhoeic keratosis
3.9
39.0
193
645
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
18.3
38.5
60
36
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
49.5
38.4
46
10
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
196.3
36.2
37
*
B07.9
ICD-10 Finland
Verruca simplex
10.2
35.9
73
80
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
35.4
35.9
46
14
L04AA06
ATC
mycophenolic acid; systemic
18.7
35.6
55
32
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
4.9
35.1
127
311
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
38.4
34.2
43
12
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
40.8
33.8
42
11
L04AD01
ATC
ciclosporin; systemic
15.4
33.1
55
39
SPAT1153
SPAT
Removal of sutures
2.8
32.7
310
1611
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
10.1
32.0
65
71
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
10.0
31.7
65
72
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
33.6
31.7
41
13
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
6.0
30.1
87
163
A12AA04
ATC
calcium carbonate; oral
14.5
30.1
51
38
L04AA01
ATC
[U] ciclosporin; systemic
16.8
29.5
47
30
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
34.6
28.1
36
11
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.2
27.7
59
70
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
56.1
27.4
32
6
L04AX01
ATC
azathioprine; systemic
7.0
27.3
70
111
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
29.3
27.0
36
13
Z2221
NOMESCO Finland
Medical doctor
2.7
26.5
247
1229
DAB00
NOMESCO Finland
Excision of lesion of auricle
17.5
26.2
41
25
TQW80
NOMESCO Finland
Local dermatologic skincare
9.1
26.2
56
67
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
26.4
25.5
35
14
J01DB01
ATC
cefalexin; oral
3.0
25.3
529
4077
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
135.4
24.8
26
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
6.5
24.7
66
111
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
36.1
24.5
31
9
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.8
23.8
189
843
205
Kela drug reimbursment
Chronic hypertension
2.4
23.4
305
1785
ZXE00
NOMESCO Finland
One hour or less
2.4
23.3
300
1744
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
12.1
23.0
42
37
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.7
23.0
83
199
A11CC03
ATC
alfacalcidol; systemic
8.5
23.0
51
65
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
22.7
152
606
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
22.2
288
1667
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
26.2
21.9
30
12
E0000UV
ATC
NA
2.3
21.6
278
1594
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
79.6
20.8
23
*
ZZA50
NOMESCO Finland
Full thickness skin graft
20.9
20.6
30
15
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
33.8
20.3
26
8
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.8
19.7
68
155
S29
ICPC
Skin symptom/complaint other
2.7
19.5
162
727
H02AB04
ATC
methylprednisolone; systemic
2.9
19.4
131
518
Z3231
NOMESCO Finland
Registered nurse
2.3
19.2
231
1262
R4110
NOMESCO Finland
Physiotherapy
2.3
18.8
220
1182
TK800
NOMESCO Finland
Hemodialysis
7.0
18.8
47
72
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.8
18.8
33
27
137
Kela drug reimbursment
Uraemia requiring dialysis
16.8
18.5
29
18
WX002
NOMESCO Finland
Sedation and analgesia
2.4
18.4
185
922
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
18.1
291
1803
L01BB01
ATC
NA
54.2
18.1
21
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
6.6
17.8
46
74
D06BX02
ATC
ingenol mebutate; topical
9.1
17.7
37
43
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
19.3
17.5
26
14
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.3
17.3
54
110
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.2
17.2
68
178
A12BA01
ATC
potassium chloride; oral
3.8
17.1
76
220
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
36.1
16.8
21
6
DAB10
NOMESCO Finland
Partial excision of auricle
20.7
16.5
24
12
N18.0
ICD-10 Finland
End-stage renal disease
9.9
16.1
32
34
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
8.1
16.1
36
47
WX110
NOMESCO Finland
Local anesthesy
2.1
16.1
407
2990
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
15.9
352
2444
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
5.6
15.9
47
90
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
17.8
15.7
24
14
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
12.2
15.7
28
24
DHB00
NOMESCO Finland
Excision of lesion of external nose
12.2
15.7
28
24
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
27.1
15.7
21
8
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
14.2
15.6
26
19
B03XA01
ATC
erythropoietin; parenteral
13.5
15.3
26
20
ZXA05
NOMESCO Finland
Left side
2.1
15.1
217
1257
S21
ICPC
Skin texture symptom/complaint
2.5
14.7
125
561
A98
ICPC
Health maint/preventive medicine
3.1
14.4
578
5077
C02CA01
ATC
prazosin; oral
6.5
14.3
37
60
7151
FHL
Kidney transplantation
43.6
14.2
17
*
ZXA00
NOMESCO Finland
Right side
2.0
14.1
224
1345
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
11.3
14.1
26
24
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
18.1
13.9
21
12
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
54.6
13.9
16
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.4
13.8
132
629
XQ845
NOMESCO Finland
Dermatoscopy
7.1
13.6
33
49
D07AB08
ATC
desonide; topical
2.8
13.4
92
364
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.4
13.3
27
30
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
41.0
13.2
16
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
15.5
13.2
21
14
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.4
13.1
39
76
S77
ICPC
Malignant neoplasm of skin
6.8
13.0
32
49
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.4
12.9
30
42
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
6.4
12.7
33
54
Z3226
NOMESCO Finland
Physiotherapist
2.2
12.5
150
792
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
132.5
12.5
13
*
D07AC01
ATC
betamethasone; topical
1.9
12.5
235
1490
B05DA
ATC
Isotonic solutions
14.7
12.3
20
14
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
12.3
116
547
ZX120
NOMESCO Finland
Intravenous
2.7
12.3
87
351
C03CA01
ATC
furosemide; systemic
1.9
12.2
289
1984
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
12.2
130
651
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
9.6
12.1
24
26
V03AE02
ATC
sevelamer; oral
21.8
12.1
17
8
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
5.0
12.0
38
80
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
47.6
11.9
14
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.0
11.9
21
18
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
16.8
11.7
18
11
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
23.4
11.6
16
7
A46
ICD-10 Finland
Erysipelas
2.2
11.6
132
679
L12
ICPC
Hand/finger symptom/complaint
2.4
11.6
102
465
D04
ICD-10 Finland
Carcinoma in situ of skin
122.2
11.5
12
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
11.4
137
723
S97
ICPC
Chronic ulcer skin
3.0
11.3
68
245
WX320
NOMESCO Finland
Spinalanesthesy
2.0
11.3
176
1033
E000001
ATC
NA
2.1
11.1
135
713
ZZA00
NOMESCO Finland
Split skin graft
4.0
11.1
44
116
3AC01
NOMESCO Finland
NA
8.8
11.1
23
27
D02AE01
ATC
carbamide; topical
3.3
11.0
57
187
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
11.0
63
222
B03XA02
ATC
darbepoetin alfa; parenteral
5.5
10.7
31
59
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
61.1
10.7
12
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
8.7
10.6
22
26
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
111.8
10.4
11
*
8070/3-C44.7
ICD-O-3
Squamous cell carcinoma, NOS, of skin of lower limb and hip
+∞
10.4
10
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
10.4
78
324
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.2
10.4
39
98
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
10.3
75
308
C02EA02
ATC
NA
2.9
10.0
61
222
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
17.0
9.9
15
9
D05BB02
ATC
acitretin; oral
5.1
9.8
30
61
WW200
NOMESCO Finland
Immunization
4.9
9.8
31
66
TQW40
NOMESCO Finland
Remowal of suture of skin
2.8
9.7
64
246
N18.8
ICD-10 Finland
Other chronic renal failure
3.5
9.7
44
131
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
11.6
9.6
17
15
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.5
9.4
44
134
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
17.9
9.4
14
8
8070/3-C44.5
ICD-O-3
Squamous cell carcinoma, NOS, of skin of trunk
22.1
9.4
13
6
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
4.0
9.4
36
93
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
9.4
59
222
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.9
9.3
25
44
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
9.1
445
3674
V03AE03
ATC
lanthanum carbonate; oral
37.3
9.0
11
*
Z94.4
ICD-10 Finland
Liver transplant status
37.3
9.0
11
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.6
8.8
66
275
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
8.6
232
1608
V03AE01
ATC
polystyrene sulfonate; oral
6.5
8.5
21
33
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.8
8.5
27
58
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
27.9
8.5
11
*
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
27.9
8.5
11
*
WXQ41
NOMESCO Finland
Photodynamic therapy of head and neck
27.9
8.5
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
8.5
246
1735
C44.69
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology
91.2
8.4
9
*
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
10.9
8.3
15
14
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
7.2
8.3
19
27
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
8.2
185
1210
S08
ICPC
Skin colour change
2.7
8.2
55
215
M04AA01
ATC
allopurinol; systemic
1.9
8.1
133
783
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.6
8.1
35
101
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
8.1
156
971
Z71.8
ICD-10 Finland
Other specified counselling
1.9
8.0
140
840
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
8.0
352
2768
N02BE01
ATC
paracetamol; systemic, rectal
1.9
7.9
532
4721
Z2446
NOMESCO Finland
Social worker
2.7
7.9
53
205
S26
ICPC
Fear of cancer of skin
6.2
7.9
20
33
S99
ICPC
Skin disease other
4.7
7.8
25
55
C03DA01
ATC
spironolactone; oral
2.0
7.8
102
553
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
45.5
7.7
9
*
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
45.5
7.7
9
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
45.5
7.7
9
*
J01FF01
ATC
clindamycin; systemic
1.7
7.7
170
1104
TQW40
SPAT
NA
3.9
7.7
30
80
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
8.2
7.6
16
20
M25.5
ICD-10 Finland
Pain in joint
1.8
7.6
146
904
40399
ICD-8 Finland
Hypertensive renal disease
18.6
7.6
11
6
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
12.0
7.6
13
11
C44.20
ICD-10 Finland
Malignant tumor of the skin of the outer ear and of the outer ear canal without histology
25.3
7.6
10
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
25.3
7.6
10
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
7.5
222
1562
C08CA02
ATC
felodipine; oral
2.0
7.5
100
545
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
7.4
278
2082
S82
ICPC
Naevus/mole
2.1
7.4
86
442
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
7.4
306
2351
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
6.1
7.4
19
32
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.6
7.4
54
221
D02AX
ATC
Other emollients and protectives
3.8
7.4
29
78
Z49.2
ICD-10 Finland
Other dialysis
8.5
7.3
15
18
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
11.0
7.3
13
12
C44
ICD-10 Finland
Other malignant neoplasms of skin
11.0
7.3
13
12
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
9.5
7.3
14
15
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
4.9
7.2
22
46
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.0
7.2
39
135
D03.5
ICD-10 Finland
Melanoma in situ of trunk
20.3
7.1
10
5
XF612
NOMESCO Finland
Measurement of central venous pressure
20.3
7.1
10
5
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
12.2
7.1
12
10
B05DB
ATC
Hypertonic solutions
10.2
7.1
13
13
SPAT1211
SPAT
Application of soft bandage
2.2
7.0
73
359
C02AC05
ATC
moxonidine; oral
2.6
7.0
49
197
R60.0
ICD-10 Finland
Localized oedema
2.0
7.0
93
506
J01CA04
ATC
amoxicillin; systemic
1.6
7.0
447
3804
ZXA10
NOMESCO Finland
Bilateral
1.8
7.0
144
912
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
7.0
133
819
J01MA12
ATC
levofloxacin; systemic
1.8
6.9
136
848
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
6.9
103
584
L85.80
ICD-10 Finland
Hudhorn
14.0
6.9
11
8
C08CA01
ATC
amlodipine; oral
1.6
6.9
285
2174
B01AA03
ATC
warfarin; systemic
1.6
6.9
189
1302
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
6.8
56
244
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
11.1
6.8
12
11
RS220
NOMESCO Finland
NA
6.2
6.8
17
28
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
40.5
6.8
8
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
16.9
6.8
10
6
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
6.8
193
1337
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.7
198
1386
C07AB07
ATC
bisoprolol; oral
1.6
6.7
355
2868
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.0
6.7
20
41
WXQ99
NOMESCO Finland
Other light therapy
22.8
6.7
9
*
ZY010
NOMESCO Finland
Hospital outpatient
3.7
6.7
27
75
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.6
263
1984
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
6.6
142
910
QCA10
NOMESCO Finland
Incision of skin of upper limb
12.4
6.6
11
9
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
8.8
6.6
13
15
196
Kela drug reimbursment
Paricalcitol and cinacalcet
10.2
6.6
12
12
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.8
6.5
26
71
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.7
6.5
43
168
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
4.6
6.5
21
47
SPAT1325
SPAT
Vaccination
1.6
6.5
265
2010
C08CA03
ATC
isradipine; systemic
4.8
6.5
20
43
K03.64
ICD-10 Finland
Dental calculus supragingival
1.8
6.5
119
724
B01AB05
ATC
enoxaparin; parenteral
1.6
6.4
213
1530
C44.92
ICD-10 Finland
Unspecified localization of spinocellular carcinoma of the skin
70.5
6.4
7
*
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
70.5
6.4
7
*
QCE99
SPAT
NA
70.5
6.4
7
*
TK820
NOMESCO Finland
Peritoneal dialysis
14.5
6.4
10
7
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
6.4
86
467
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
8.3
6.4
13
16
J05AB01
ATC
aciclovir; systemic
1.8
6.4
123
761
ZXC10
NOMESCO Finland
Use of laser
4.1
6.3
23
58
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
6.3
144
938
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
11.2
6.3
11
10
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
6.3
208
1496
QWC00
NOMESCO Finland
Reoperation for superficial infection in surgery of skin
18.2
6.3
9
5
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
6.3
6
*
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
+∞
6.3
6
*
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
27.0
6.2
8
*
Z94.1
ICD-10 Finland
Heart transplant status
27.0
6.2
8
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
6.4
6.2
15
24
C02LM02
ATC
NA
4.3
6.2
21
50
L84
ICD-10 Finland
Corns and callosities
3.0
6.2
33
114
L17
ICPC
Foot/toe symptom/complaint
1.6
6.2
166
1129
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.2
6.1
30
98
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
6.8
6.1
14
21

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
590
2322
9.53
152.03
5.3
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
327
765
7.00
145.61
2.4
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
135
275
5.81
65.22
1.5
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
114
6.17
36.13
6.6
5.3
iu/ml
301.9
341.0
—
8
16
(3006315) Basophils [#/volume] in Blood
465
2904
2.70
35.18
8.8
5.2
e9/l
0.0
0.0
1.07
404
2461
(3001604) Monocytes [#/volume] in Blood
463
2891
2.69
34.94
8.8
5.2
e9/l
0.6
0.6
0.02
400
2439
(3019198) Lymphocytes [#/volume] in Blood
467
2950
2.66
34.05
8.9
5.3
e9/l
2.0
1.9
0.42
403
2549
(42870588) Differential panel, method unspecified - Blood
364
2043
2.58
34.02
8.0
5.3
—
—
—
0
0
(4035726)
153
548
3.28
33.59
1.5
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
469
2991
2.63
33.15
9.3
5.3
e9/l
0.2
0.2
2.08
408
2576
(3022096) Basophils/100 leukocytes in Blood
430
2658
2.53
32.05
9.3
5.5
%
0.6
0.6
0.02
402
2458
(36304419) Bacteria [Presence] in Urine
335
1851
2.51
31.78
5.2
3.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
437
2732
2.53
31.62
9.5
5.8
%
9.2
8.9
1.01
408
2531
(3030467) Casts [#/volume] in Urine by Automated count
346
1946
2.50
31.51
5.5
3.4
e6/l
0.5
0.6
0.39
289
1506
(3006504) Eosinophils/100 leukocytes in Blood
434
2719
2.50
31.03
9.3
5.5
%
2.6
2.8
1.39
401
2509
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
72
160
4.89
30.82
4.7
2.7
mg/l
2.1
1.8
1.28
64
140
(3018010) Neutrophils/100 leukocytes in Blood
433
2721
2.48
30.58
9.0
5.5
%
58.3
59.1
0.65
402
2521
(3002030) Lymphocytes/100 leukocytes in Blood
437
2770
2.47
30.09
9.4
5.7
%
26.2
25.3
0.73
404
2545
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
150
567
3.08
29.81
6.5
3.7
ng/l
127.3
97.8
1.39
132
480
(40758558) Short blood count panel - Blood
277
1479
2.42
27.40
9.2
6.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
453
2999
2.38
27.09
6.6
4.6
g/l
33.7
34.4
1.52
415
2764
(3021589) Normoblasts [#/volume] in Blood
407
2578
2.33
26.94
14.6
10.4
e9/l
0.0
0.0
0.65
338
2101
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
614
4728
3.03
25.83
11.0
7.5
u/l
83.2
80.4
0.61
581
4386
(3013650) Neutrophils [#/volume] in Blood by Automated count
490
3401
2.38
25.60
12.5
8.6
e9/l
4.1
4.3
1.08
429
2949
(3002582) Erythrocytes [#/volume] in Urine
352
2130
2.28
25.55
5.8
3.6
e6/l
52.8
115.0
1.02
292
1675
(3000850) Epithelial cells [#/volume] in Urine
276
1509
2.34
25.49
4.1
2.7
e6/l
3.7
5.0
1.67
258
1324
(3018095) Leukocytes [#/volume] in Urine
381
2394
2.26
25.09
6.4
4.1
e6/l
68.4
142.0
1.04
300
1783
(3018418) pH of Serum or Plasma
342
2070
2.24
24.52
8.6
4.1
ph
7.4
7.4
0.11
64
401
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
393
2524
2.23
24.23
6.2
3.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
231
1208
2.34
23.28
4.4
3.0
e6/l
0.7
1.5
1.48
155
720
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
455
3137
2.22
23.02
11.2
6.0
mmol/l
1.2
1.2
0.42
412
2815
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
485
3433
2.26
22.96
11.8
6.8
mmol/l
1.2
1.2
0.50
403
2882
(3004789) Transferrin [Mass/volume] in Serum or Plasma
207
1042
2.38
22.68
3.8
2.5
g/l
2.2
2.2
1.44
192
950
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
678
5670
4.36
22.12
29.2
18.2
mg/l
28.8
27.6
0.39
598
4694
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
98
341
3.17
22.11
5.7
4.0
mmol/l
23.8
23.9
0.18
90
304
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
177
845
2.45
21.72
4.8
3.8
u/l
260.6
247.8
0.47
169
788
(3003458) Phosphate [Moles/volume] in Serum or Plasma
189
935
2.38
21.39
12.3
5.0
mmol/l
1.0
1.0
0.07
181
853
(3031040) Bacteria [#/volume] in Urine by Automated count
555
4233
2.36
20.81
6.8
5.3
e6/l
582.2
3705.9
—
6
76
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
196
997
2.33
20.73
4.0
2.6
%
21.3
21.8
0.17
172
835
(3000991) Gas panel - Venous blood
138
603
2.59
20.32
10.8
7.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
276
1625
2.13
20.25
4.7
2.9
umol/l
4209.3
10134.1
1.21
242
1361
(3023368) Bacteria identified in Blood by Culture
334
2117
2.08
20.09
6.6
4.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
690
5926
4.94
19.77
16.4
11.4
u/l
23.6
23.7
0.09
670
5644
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
640
5289
2.89
18.87
28.4
17.4
ml/min/173m2
63.8
70.5
11.21
558
4385
(3022948) Iron [Moles/volume] in Serum or Plasma
210
1139
2.19
18.77
3.8
2.5
umol/l
11.3
12.1
0.91
198
1033
(3007853) Bacteria identified in Skin by Aerobe culture
158
761
2.38
18.75
2.7
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
691
5981
4.86
18.67
34.5
22.1
mmol/l
139.2
139.5
2.00
683
5807
(3012095) Magnesium [Moles/volume] in Serum or Plasma
204
1101
2.19
18.42
3.5
3.1
mmol/l
0.8
0.8
2.76
189
1025
(3023103) Potassium [Moles/volume] in Serum or Plasma
691
5992
4.80
18.38
35.6
22.2
mmol/l
4.0
4.0
1.01
681
5814
(3001122) Ferritin [Mass/volume] in Serum or Plasma
361
2411
2.00
18.22
3.9
2.8
ug/l
168.7
159.1
0.28
327
2149
(3013707) Erythrocyte sedimentation rate by Westergren method
559
4382
2.23
17.94
5.2
4.2
mm/h
17.4
15.1
1.85
499
3947
(3007461) Platelets [#/volume] in Blood
696
6083
5.33
17.94
40.6
26.8
e9/l
231.9
236.6
0.80
681
5893
(3024731) MCV [Entitic volume]
696
6083
5.33
17.94
40.6
26.7
fl
92.5
91.9
2.12
689
5953
(3026361) Erythrocytes [#/volume] in Blood
696
6084
5.32
17.91
40.7
26.8
e12/l
4.3
4.4
1.65
677
5867
(3035941) MCH [Entitic mass]
696
6084
5.32
17.91
40.5
26.7
pg
30.5
30.5
0.37
689
5953
(3000963) Hemoglobin [Mass/volume] in Blood
696
6085
5.31
17.88
40.9
27.0
g/l
129.7
131.6
2.53
689
5951
(3010813) Leukocytes [#/volume] in Blood
696
6086
5.31
17.86
40.7
26.8
e9/l
7.1
7.0
0.44
676
5868
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
366
2469
1.98
17.81
2.7
2.2
nmol/l
81.9
79.5
0.84
315
2117
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
642
5383
2.78
17.06
7.6
6.7
mmol/mol
40.6
41.3
1.27
580
4853
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
21
9.77
17.06
2.4
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
206
1155
2.10
16.62
4.8
3.2
e6/l
1.2
2.3
1.84
131
673
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
656
5585
2.96
16.46
6.1
5.4
mmol/l
2.3
2.5
6.16
576
4954
(3042936) Bacteria identified in Isolate by Culture
183
989
2.14
16.21
2.2
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
452
3348
1.94
15.97
7.0
6.1
umol/l
12.4
11.9
0.60
434
3165
(40761511) CBC panel - Blood by Automated count
668
5767
3.19
15.84
22.7
17.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
16
14
11.67
15.36
1.7
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
537
4251
2.04
15.23
7.0
4.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
356
2466
1.88
15.18
3.3
3.3
ng/l
2553.2
1832.1
1.70
312
2139
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
91
373
2.65
15.05
2.0
2.0
g/l
1.6
1.6
0.06
75
328
(3026782) Osmolality of Urine
240
1470
1.95
14.85
4.7
3.0
mosm/kgh2o
526.2
551.8
1.34
209
1246
(46235355) HIV 1 and 2 tests - Meaningful Use set
110
499
2.42
14.70
1.9
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
229
1390
1.95
14.49
4.4
4.2
ng/l
205.5
289.4
0.39
206
1212
(3002032) Base excess in Venous blood by calculation
138
706
2.18
13.86
5.4
3.6
mmol/l
1.4
2.0
0.93
110
547
(3013826) Glucose [Moles/volume] in Serum or Plasma
490
3829
1.88
13.54
7.0
5.0
mmol/l
6.7
6.9
0.82
467
3619
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
353
2503
1.80
13.39
2.5
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
576
4766
2.04
13.18
33.5
20.2
%
38.9
38.0
2.01
380
2831
(3021447) Carbon dioxide [Partial pressure] in Venous blood
137
712
2.14
13.18
5.5
3.6
kpa
5.7
5.8
0.64
129
685
(3044889) 12 lead EKG panel
530
4264
1.92
13.17
5.6
4.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
279
1852
1.83
13.10
2.6
2.2
mg/l
2.9
3.2
1.50
237
1559
(3032080) INR in Blood by Coagulation assay
406
3018
1.79
12.98
14.2
11.8
inr
1.4
1.4
0.64
106
833
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
110
533
2.26
12.56
1.8
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
609
5172
2.15
12.55
5.1
4.8
mu/l
2.0
2.0
0.22
543
4561
(3012516) Albumin [Mass/volume] in Urine
295
2011
1.79
12.55
4.6
3.3
mg/l
278.8
367.9
0.17
221
1287
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
610
5185
2.16
12.52
5.0
4.2
mmol/l
1.3
1.3
1.35
535
4524
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
395
2934
1.77
12.46
2.4
2.2
pmol/l
90.3
92.8
0.48
197
1494
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
630
5430
2.28
12.37
5.6
4.8
mmol/l
4.3
4.4
2.91
561
4851
(3015377) Calcium [Moles/volume] in Serum or Plasma
331
2342
1.77
12.33
4.1
3.3
mmol/l
2.4
2.3
0.97
277
1990
(3052851) Hemolysis interference index of Serum or Plasma
57
203
2.96
12.25
5.2
3.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
294
2020
1.77
12.05
4.5
3.1
mmol/l
6.0
7.0
5.30
248
1616
(3020630) Protein [Mass/volume] in Serum or Plasma
125
649
2.12
11.99
2.4
3.0
g/l
63.2
65.7
3.05
118
581
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
622
5366
2.17
11.66
5.5
4.7
mmol/l
1.4
1.4
0.03
550
4739
(3021960) Folate [Moles/volume] in Serum or Plasma
268
1810
1.77
11.54
1.7
1.6
nmol/l
19.9
20.3
0.15
225
1509
(3014111) Lactate [Moles/volume] in Serum or Plasma
123
645
2.09
11.46
9.3
6.4
mmol/l
1.3
1.4
1.40
115
614
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
222
1422
1.81
11.42
3.2
3.2
mmol/l
2.5
2.5
0.45
187
1240
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
101
491
2.23
11.40
2.1
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
236
1547
1.78
11.19
3.3
2.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
322
2305
1.72
11.17
4.1
3.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
64
256
2.65
11.07
2.6
3.4
g/l
0.6
1.4
1.49
59
214
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
158
917
1.93
11.04
2.4
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
303
2148
1.71
10.79
5.5
4.0
mg/mmol
18.3
8.7
1.90
215
1359
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
110
569
2.10
10.59
3.1
2.3
u/l
32.2
35.3
0.30
93
477
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
201
1276
1.80
10.52
2.4
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
200
1270
1.80
10.45
1.7
1.7
mg/l
2.5
1.4
0.77
160
1011
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
96
474
2.18
10.41
3.0
3.0
ml/min/173m2
52.6
55.5
0.38
45
203
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
280
2.49
10.13
2.5
3.0
g/l
3.3
3.2
0.17
60
211
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
306
2.39
9.62
2.5
2.9
g/l
4.1
3.7
0.98
59
207
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
153
916
1.85
9.60
2.3
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
307
2.38
9.55
2.5
2.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
307
2.38
9.55
2.5
2.9
g/l
7.3
7.5
0.30
61
213
(3004588) Protein electrophoresis panel - Serum or Plasma
104
549
2.05
9.45
2.4
2.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
377
2896
1.63
9.43
4.6
4.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
154
929
1.84
9.42
3.4
2.4
%
1.8
1.8
0.32
138
823
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
76
3.79
9.24
1.1
1.1
u/ml
355.3
313.4
0.20
17
40
(3017143) Hepatitis C virus Ab [Presence] in Serum
82
399
2.19
9.20
2.1
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
81
3.69
9.19
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
96
3.44
9.13
1.4
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
121
689
1.91
8.83
3.2
2.7
umol/l
8.3
8.7
0.09
111
603
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
84
420
2.13
8.80
2.1
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
285
2073
1.62
8.69
3.4
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
125
723
1.88
8.69
1.7
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
625
5546
1.96
8.66
5.9
5.2
mmol/l
6.1
6.1
0.01
546
4887
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
282
2.35
8.60
2.7
2.6
u/ml
0.3
0.4
0.11
39
163
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
78
393
2.10
8.00
11.5
8.9
mmol/l
24.5
24.6
0.09
70
365
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
127
762
1.81
7.81
4.9
3.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
57
255
2.34
7.80
1.4
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
54
238
2.37
7.65
1.3
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
104
597
1.87
7.35
4.0
2.9
kpa
5.0
4.3
2.19
99
570
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
100
3.09
7.27
1.8
1.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
276
2058
1.55
7.25
2.7
2.2
u/l
142.0
255.7
2.00
254
1925
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
121
735
1.78
7.11
3.1
3.1
ng/l
300.0
256.5
0.42
107
674
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
102
3.03
7.04
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
147
946
1.70
7.04
1.9
1.5
g/l
2.7
2.7
0.06
72
531
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
500
4261
1.57
6.99
3.7
3.8
pmol/l
15.1
15.2
0.55
430
3724
(3036481) Cortisol [Moles/volume] in Serum or Plasma
93
528
1.87
6.80
3.1
1.8
nmol/l
394.2
385.0
0.08
85
474
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
28
5.08
6.73
1.3
2.5
e6/l
511.8
505.1
—
5
11
(3003338) MCHC [Mass/volume]
508
4371
1.55
6.56
40.5
24.6
g/l
329.7
330.8
1.96
508
4334
(3034860) Kappa light chains.free [Mass/volume] in Serum
56
271
2.16
6.39
3.3
3.8
mg/l
79.5
84.2
0.05
46
219
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
120
2.74
6.33
1.5
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
201
1432
1.56
6.31
5.1
4.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
66
342
2.02
6.29
1.2
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
55
266
2.16
6.28
3.3
3.8
—
2.0
—
0
22
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
56
273
2.14
6.27
3.2
3.8
mg/l
35.8
96.3
0.74
46
224
(3021601) Nitrite [Presence] in Urine by Test strip
366
2960
1.48
6.24
7.6
5.9
estimate
0.0
0.0
0.00
80
562
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
29
105
2.84
6.12
1.5
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
38
159
2.47
6.06
3.5
2.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
23
5.29
6.02
1.8
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
135
886
1.64
5.93
9.0
6.5
kpa
5.0
5.1
0.38
126
846
(3027801) Oxygen [Partial pressure] in Arterial blood
135
887
1.64
5.91
8.9
6.5
kpa
11.8
11.6
0.19
126
847
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
115
2.68
5.71
5.9
2.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
111
699
1.70
5.70
3.5
2.5
e9/l
65.7
68.9
0.51
70
555
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
41
183
2.32
5.69
1.4
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
43
196
2.27
5.68
1.7
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
10
17
5.95
5.64
1.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
366
3000
1.45
5.59
5.7
4.4
estimate
0.0
0.0
0.00
79
555
(3022217) INR in Platelet poor plasma by Coagulation assay
155
1068
1.58
5.55
43.3
32.2
inr
1.7
1.4
0.98
17
123
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
29
4.55
5.53
1.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
129
2.55
5.52
1.7
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
106
2.71
5.46
3.1
2.8
e9/l
4.0
4.7
0.94
28
106
(3035350) Ketones [Presence] in Urine by Test strip
361
2960
1.44
5.46
5.8
4.3
estimate
0.0
0.0
0.00
82
569
(3003396) Base excess in Arterial blood by calculation
133
887
1.61
5.46
9.0
6.5
mmol/l
0.6
1.4
1.20
103
690
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
25
89
2.87
5.46
1.4
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
257
1979
1.46
5.42
3.3
2.4
u/l
70.5
57.7
0.86
234
1807
(3003327) Ova and parasites identified in Stool by Light microscopy
32
131
2.51
5.36
1.7
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
70
3.06
5.14
6.0
3.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
81
2.90
5.13
1.7
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
30
123
2.50
5.02
3.7
2.0
%
62.1
60.6
0.11
30
123
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
82
2.86
5.02
4.8
3.8
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
111
2.58
5.01
3.9
3.2
%
57.7
60.5
0.50
28
111
(3005719) IgG [Mass/volume] in Serum or Plasma
73
423
1.81
5.01
4.2
2.8
g/l
9.2
11.1
3.02
65
378
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
61
3.17
4.94
1.8
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
99
628
1.67
4.94
1.6
1.3
titre
460.0
477.5
0.04
18
146
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
169
2.25
4.89
1.8
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
314
2547
1.41
4.86
5.4
5.8
ug/l
2.8
3.7
0.75
272
2242
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
37
3.84
4.83
1.1
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
37
3.84
4.83
1.1
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
10
9.10
4.79
13.1
6.8
mmol/l
8.9
7.2
—
9
10
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
63
3.07
4.70
1.3
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38
179
2.19
4.68
1.8
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
198
1488
1.46
4.62
1.7
1.6
mmol/l
1.4
1.3
0.68
167
1200
(3011412) CD3 cells [#/volume] in Blood
14
39
3.64
4.50
1.7
2.2
e9/l
1.1
0.9
—
8
24
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
385
3261
1.39
4.50
3.3
3.2
u/l
60.4
54.8
0.46
345
2939
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
147
1047
1.51
4.47
1.2
1.2
u/ml
1.3
1.3
0.04
18
246
(3037756) Immunofixation for Serum or Plasma
38
184
2.12
4.39
1.5
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
192
1456
1.43
4.22
3.4
3.4
ug/l
0.8
0.8
0.01
138
1037
(3000492) Spirometry study
71
431
1.72
4.18
1.8
1.6
—
—
—
0
0
(44790047)
21
80
2.67
4.09
2.0
1.4
—
—
—
0
0
(44806118)
21
80
2.67
4.09
2.0
1.3
—
—
—
0
0
(44790049)
21
80
2.67
4.09
2.0
1.4
—
—
—
0
0
(44790048)
21
80
2.67
4.09
2.0
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
57
330
1.79
3.95
2.4
1.8
ug/l
4.4
2.3
0.36
52
283
(40767503) Oxygen content in Capillary blood by calculation
33
158
2.14
3.94
3.3
2.5
%
15.0
15.6
0.35
19
79
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
145
2.19
3.92
1.5
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
35
172
2.09
3.91
1.5
1.4
ug/g
265.0
267.9
0.03
23
98
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
255
2054
1.37
3.90
4.4
4.9
%
23.2
21.5
0.86
121
1104
(3021440) Promyelocytes/100 leukocytes in Blood
78
498
1.64
3.81
5.5
4.1
%
0.2
0.1
0.28
31
150
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
8
8.82
3.78
1.6
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
72
453
1.65
3.73
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
221
1751
1.38
3.71
3.9
2.9
u/l
30.7
35.2
1.34
209
1659
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
90
601
1.57
3.66
7.8
3.9
mmol/l
1.2
1.2
0.25
80
521
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
30
3.71
3.65
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
74
472
1.63
3.64
5.4
4.1
%
0.0
0.8
0.59
26
130
(4010399)
68
426
1.66
3.58
1.4
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
81
535
1.58
3.46
5.5
4.0
%
0.7
0.9
0.39
34
166
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
16
58
2.80
3.44
1.0
1.1
g/l
1.5
1.6
0.29
16
52
(3028026) IgM [Mass/volume] in Serum or Plasma
56
339
1.71
3.36
3.3
1.8
g/l
1.3
1.5
0.27
50
306
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
32
162
2.02
3.34
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
32
162
2.02
3.34
1.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
149
2.06
3.30
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
116
837
1.46
3.28
1.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
60
2.70
3.24
1.1
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
151
1146
1.40
3.24
7.0
4.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
48
282
1.75
3.21
2.7
2.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
14
49
2.89
3.20
1.5
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
10
28
3.61
3.20
1.7
1.7
—
33.8
—
0
5
(3004119) Hemoglobin [Mass/volume] in Venous blood
72
472
1.58
3.18
4.0
3.0
g/l
124.4
125.0
0.09
67
460
(3002179) Metamyelocytes/100 leukocytes in Blood
72
472
1.58
3.18
4.8
3.9
%
0.3
0.6
0.76
22
123
(3048689) Calprotectin [Mass/mass] in Stool
79
530
1.55
3.16
2.5
2.0
ug/g
187.8
159.6
0.23
64
402
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
20
4.54
3.12
1.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
93
649
1.50
3.11
1.5
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
39
3.11
3.10
5.8
3.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
8
7.55
3.06
1.3
3.0
%
252.4
150.7
—
6
8
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
92
645
1.49
3.01
2.3
2.0
g/l
0.2
0.2
3.83
86
597
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
328
1.66
2.96
1.2
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
31
166
1.91
2.80
3.4
5.2
mmol/l
2.4
2.6
0.29
21
112
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
31
3.26
2.78
2.4
1.5
g/l
0.9
1.0
—
10
31
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
78
2.34
2.76
1.6
1.5
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
14
54
2.62
2.71
1.4
1.3
u/l
14.9
13.6
0.23
14
48
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
61
402
1.57
2.67
13.6
8.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
31
170
1.86
2.62
1.4
1.5
iu/ml
0.1
25.6
—
6
47
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
80
2.28
2.62
1.6
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
67
453
1.53
2.62
1.4
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
29
156
1.90
2.60
4.0
4.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
109
812
1.40
2.60
1.2
1.3
iu/ml
55.9
38.8
0.30
31
267
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
22
107
2.09
2.59
1.5
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
20
94
2.16
2.57
1.6
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
75
2.30
2.52
2.2
2.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
35
203
1.76
2.49
1.7
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
23
116
2.02
2.48
1.5
1.3
e6/l
1847.5
1361.5
0.23
11
85
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
181
1.80
2.47
1.6
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
145
1.90
2.45
3.4
2.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
103
2.07
2.44
1.5
1.5
—
—
—
0
0
(3013512) EKG study
242
2047
1.27
2.40
4.5
4.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
24
125
1.95
2.38
1.7
1.4
—
—
—
0
0
(3025315) Body weight
5
8
6.28
2.37
10.6
3.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
41
2.71
2.28
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
186
1.75
2.28
1.3
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
13
4.64
2.27
1.3
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
66
2.30
2.25
1.6
1.9
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
15
66
2.30
2.25
1.1
1.2
u/l
10.4
15.4
0.71
15
57
(40760888) Immunoglobulin light chains.free panel - Serum
34
202
1.72
2.25
3.6
4.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
80
2.15
2.20
1.6
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
48
2.53
2.19
1.5
1.4
—
—
—
0
0
(4062490)
11
42
2.64
2.19
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
23
122
1.91
2.18
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
30
3.02
2.15
2.0
2.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
81
2.13
2.14
1.6
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
81
2.13
2.14
1.6
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
68
2.23
2.12
1.7
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
68
2.23
2.12
1.0
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
102
1.99
2.12
1.5
1.3
e6/l
141977.8
93915.7
—
6
61
(3019060) Gas panel - Arterial blood
75
545
1.42
2.08
3.8
4.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
82
2.10
2.08
1.6
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
184
1.72
2.07
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
72
520
1.43
2.07
1.2
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
314
2779
1.23
2.02
4.3
4.3
ng/l
1310.0
57.9
0.50
250
2195
(3012441) Differential panel - Pleural fluid
19
97
1.98
2.02
1.5
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
97
1.98
2.02
1.5
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
32
2.83
2.00
2.0
3.0
nmol/l
302.1
112.3
—
9
32
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
25
141
1.80
1.99
1.5
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
51
2.38
1.96
1.4
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
11
4.57
1.94
1.2
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
11
4.57
1.94
1.2
2.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
11
4.57
1.94
5.8
6.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
11
4.57
1.94
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
16
3.77
1.94
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
100
776
1.34
1.88
3.1
4.0
ug/l
3.5
27.9
1.62
79
656
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
13
59
2.23
1.85
1.4
1.2
u/l
87.4
52.0
—
8
42
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
183
1.67
1.84
1.3
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
21
115
1.85
1.84
4.8
4.2
%
1.4
1.4
0.00
16
94
(3000475) Leukocytes [#/volume] in Synovial fluid
27
160
1.71
1.84
1.6
1.7
e6/l
15186.0
21324.3
0.47
20
117
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
17
3.55
1.84
1.2
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
73
2.08
1.81
1.1
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
60
2.19
1.78
1.6
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
47
2.36
1.78
1.3
1.5
—
—
—
0
0
(4306422)
11
47
2.36
1.78
1.1
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
185
1.65
1.78
4.0
2.6
ug/min
153.1
97.1
0.29
21
110
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
95
1.92
1.76
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
132
1.77
1.75
2.3
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
54
2.24
1.74
1.8
1.5
%
10.8
10.7
0.01
12
54
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
96
1.90
1.72
1.4
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
55
2.20
1.68
1.3
1.1
u/ml
1.2
1.9
—
6
17
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
692
1.33
1.66
2.2
2.6
ug/l
4.7
6.4
1.09
76
596
(3023420) DNA double strand Ab [Units/volume] in Serum
10
43
2.34
1.61
1.7
1.2
—
38.4
—
0
5
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
32
2.52
1.60
2.9
4.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
215
1.56
1.59
1.3
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
53
382
1.42
1.58
2.4
2.1
nmol/l
11.0
11.7
0.24
47
328
(3006184) Hemoglobin [Mass/volume] in Capillary blood
26
160
1.65
1.58
3.3
2.1
g/l
117.1
126.9
1.22
21
116
(3037121) Protein [Mass/volume] in Urine
36
242
1.51
1.53
5.4
2.8
g/l
0.4
0.3
0.42
21
87
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
59
437
1.38
1.52
5.6
4.0
mmol/l
0.8
2.1
2.34
46
333
(3045142) Bone marrow Pathology biopsy report
16
86
1.88
1.51
1.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
86
1.88
1.51
1.9
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
194
1.57
1.51
1.2
1.4
—
—
—
0
0
(3020891) Body temperature
43
301
1.46
1.50
5.8
4.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
1.6
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
61
458
1.36
1.45
5.5
4.0
ph
7.4
7.4
0.61
15
56
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
59
2.05
1.44
1.2
1.2
u/ml
2.7
7.9
—
6
27
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
22
2.74
1.43
1.0
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
185
1602
1.21
1.41
1.7
1.8
nmol/l
993.9
1212.4
3.21
135
1182
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
40
2.27
1.40
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
40
2.27
1.40
1.6
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
23
2.62
1.37
1.3
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
17
2.95
1.36
1.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
42
2.16
1.34
1.8
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
42
2.16
1.34
1.8
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
68
1.93
1.34
1.4
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
68
1.93
1.34
1.4
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
68
1.93
1.34
1.4
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
100
815
1.26
1.34
12.3
9.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
131
0.45
1.29
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
69
541
1.30
1.25
7.8
4.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
36
2.24
1.24
1.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
18
108
1.68
1.23
1.3
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
56
1.98
1.22
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
37
2.17
1.21
1.4
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
39
281
1.41
1.21
3.1
3.2
u/ml
39.2
4989.8
0.78
32
240
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
38
2.12
1.18
1.4
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
38
2.12
1.18
1.1
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
378
1.35
1.17
2.8
2.6
—
—
—
0
0
(4094501)
22
142
1.57
1.15
1.2
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
20
2.51
1.15
1.4
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
65
1.86
1.14
1.7
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
8
40
2.01
1.12
1.5
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
51
1.97
1.11
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
23
152
1.53
1.10
2.7
2.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
34
244
1.41
1.09
2.4
2.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
21
2.39
1.09
4.0
1.9
—
—
—
0
0
(4268621)
8
41
1.96
1.09
1.9
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
155
1355
1.18
1.06
1.2
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
73
591
1.26
1.06
6.0
3.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
92
767
1.23
1.04
1.2
1.3
u/ml
6.3
12.9
0.71
22
245
(3019225) pH of Specimen
84
694
1.24
1.03
7.3
4.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
45
345
1.32
0.99
2.9
2.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
61
1.82
0.99
1.6
1.2
nmol/l
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
150
1.48
0.94
1.5
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
9
52
1.74
0.92
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
55
1.83
0.92
1.2
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
28
2.15
0.91
2.2
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
12
71
1.70
0.89
2.3
3.9
%
72.3
53.9
—
6
54
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
42
1.91
0.88
2.0
2.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
13
79
1.66
0.88
1.0
1.3
mosm/kgh2o
278.5
274.1
—
6
49
(3023410) Appearance of Cerebral spinal fluid
8
43
1.87
0.87
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
30
2.01
0.87
1.8
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
96
1.57
0.85
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
301
1.31
0.84
1.6
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
81
1.62
0.81
3.0
2.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
235
0.67
0.80
7.6
5.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
48
1.67
0.79
1.0
1.1
—
—
—
0
0
(4015189)
0
26
0.00
0.78
0.0
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
74
1.63
0.78
1.1
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
54
1.67
0.74
3.1
2.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
24
2.09
0.74
1.2
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
24
2.09
0.74
3.2
1.7
u/ml
3081.0
1409.8
—
5
24
(3032773) Endomysium IgG Ab [Titer] in Serum
7
38
1.85
0.73
1.3
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
38
1.85
0.73
2.6
2.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
39
1.80
0.72
8.4
4.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
40
1.76
0.71
3.3
2.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
59
1.53
0.68
1.1
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
1.9
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
102
1.48
0.68
4.8
2.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
268
1.28
0.66
2.5
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
31
242
1.29
0.65
4.5
3.5
mmol/l
3.9
4.0
0.39
31
221
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
137
1.40
0.65
1.3
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
2.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
2.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
47
391
1.22
0.60
1.7
1.6
%
1.5
1.7
1.26
42
313
(4024509)
8
55
1.46
0.56
1.9
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
124
0.64
0.55
3.6
2.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
117
1.38
0.52
1.6
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
63
1.43
0.52
1.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
241
2275
1.09
0.49
6.9
4.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
76
1.45
0.48
1.1
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
45
386
1.18
0.44
4.5
3.2
mmol/l
24.3
25.2
1.30
40
373
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
31
1.62
0.43
1.4
1.5
mg/l
35.6
75.1
—
5
23
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
16
0.00
0.41
0.0
1.6
—
1.2
—
0
16
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
59
1.36
0.41
1.1
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
17
0.00
0.40
0.0
1.6
—
15.2
—
0
12
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
160
0.75
0.40
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
9.3
—
0
18
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
216
1.21
0.37
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
16
125
1.29
0.37
1.5
1.2
u/ml
2.9
2.4
—
5
22
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
71
1.27
0.36
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
77
0.65
0.36
2.8
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
176
1663
1.08
0.36
7.3
4.5
estimate
0.0
0.0
0.00
77
533
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
78
0.64
0.35
1.2
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
292
1.17
0.35
2.6
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
500
1.13
0.35
1.6
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
74
1.36
0.32
1.2
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
7
53
1.32
0.31
1.0
1.1
—
2.3
—
0
14
(3030981) Hyaline casts [#/volume] in Urine by Automated count
44
394
1.12
0.28
6.4
3.2
e6/l
0.4
0.5
0.17
44
389
(3041096) Erythrocytes [Presence] in Urine by Automated
164
1563
1.06
0.27
6.1
4.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
74
1.22
0.25
1.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
84
785
1.08
0.24
5.1
4.9
%
37.8
33.2
2.82
52
494
(3022621) pH of Urine by Test strip
41
453
0.90
0.24
2.7
3.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.0
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.0
1.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
41
1.22
0.22
23.6
16.9
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
17.4
—
0
10
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
8.7
—
0.7
—
0
12
(3022689) Creatine [Moles/volume] in Urine
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
37
336
1.11
0.20
6.5
4.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
108
1.21
0.20
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
6
51
1.18
0.19
1.0
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
51
1.18
0.19
1.3
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
6
53
1.13
0.18
1.2
1.1
—
184.5
—
0
13
(40768800) Prostate Pathology biopsy report
20
175
1.15
0.18
1.4
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
14
120
1.17
0.16
1.6
1.1
—
92.2
—
0
9
(3042631) Mycobacterium sp identified in Specimen
13
111
1.17
0.16
2.8
2.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
79
0.76
0.15
1.8
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
83
1.09
0.14
5.4
5.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
26
237
1.10
0.14
4.5
5.6
mmol/l
1.3
1.4
0.46
20
204
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
28
257
1.09
0.13
2.4
3.0
pmol/l
4.2
4.3
0.24
21
226
(3044927) Protein electrophoresis panel - Urine
11
94
1.17
0.13
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
110
0.82
0.13
1.7
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
110
0.82
0.13
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
39
365
1.07
0.12
2.4
3.2
e9/l
4.3
4.1
0.11
21
260
(40768441) Liver Pathology biopsy report
5
44
1.14
0.10
1.4
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
44
1.14
0.10
4.2
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
164
1.10
0.10
4.2
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
55
1.09
0.09
1.5
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
6
57
1.05
0.08
1.0
1.2
mmol/l
28.2
32.4
—
6
52
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
58
1.03
0.08
2.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
66
1.06
0.08
1.4
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
112
0.89
0.07
1.7
1.5
—
—
—
0
0
(4146454)
8
78
1.03
0.07
2.3
2.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
89
1.13
0.07
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
92
0.87
0.06
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
41
395
1.04
0.05
6.9
4.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
100
1.10
0.05
1.1
1.3
—
—
—
0
0
(4034850)
18
191
0.94
0.04
10.2
12.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
240
0.96
0.03
1.1
1.1
iu/ml
214.3
138.5
—
5
87
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
179
0.95
0.03
2.0
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
150
1486
1.01
0.03
3.8
3.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
118
0.93
0.03
1.2
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
158
1593
0.99
0.02
1.8
1.8
pmol/l
407.2
9162538.3
0.80
120
1277
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
127
0.94
0.01
1.5
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
116
0.95
0.00
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
131
1317
0.99
0.00
6.6
4.9
kg/l
1.0
1.0
0.67
21
209
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
13.0
—
0
6
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
9
0.00
0.00
0.0
2.6
—
13.2
—
0
9
(3005033) Fetal Nuchal fold Thickness US
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
87
0.92
0.00
1.4
1.6
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
8.9
—
897.4
—
0
9
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
11.2
—
1523.3
—
0
9
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
3.7
—
0.7
—
0
6
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
6
59
1.02
0.00
1.0
1.3
e6/l
169015.0
198757.2
—
6
37
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
70
1.00
0.00
1.3
1.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
5
0.00
0.00
0.0
1.0
—
8.2
—
0
5
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_SKIN_UPPERLIMB – Carcinoma in situ of skin of upper limb, including shoulder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).